Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OmegaVia is a consumer health company specializing in the development and commercialization of high-purity, pharmaceutical-grade omega-3 dietary supplements. The company focuses on providing concentrated eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) formulations designed to support cardiovascular, brain, and joint health. OmegaVia utilizes advanced purification techniques, such as molecular distillation and CO2 extraction, to ensure its products are free from environmental toxins and heavy metals. Managed by Innovix Pharma, the brand targets consumers and healthcare practitioners seeking clinical-strength nutritional support with transparent sourcing and science-based dosing. Their product line includes specialized oils for triglyceride management, prenatal health, and inflammatory response support.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OmegaVia.